Evidence map›Paper›PMID 37084728›Full record

ArticleDevelopmental cell2023

Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cells.

Valeria Amodeo, Timothy Davies, Amalia Martinez-Segura, Melanie P Clements, Holly Simpson Ragdale, Andrew Bailey, Mariana Silva Dos Santos, James I MacRae, Joao Mokochinski, Holger Kramer and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Developmental cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Valeria AmodeoSamantha Dickson Brain Cancer Unit, UCL Cancer Institute, London WC1E 6DD, UK.
Timothy DaviesSamantha Dickson Brain Cancer Unit, UCL Cancer Institute, London WC1E 6DD, UK.
Amalia Martinez-SeguraMRC London Institute of Medical Sciences, Du Cane Road, London W12 0NN, UK; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
Melanie P ClementsSamantha Dickson Brain Cancer Unit, UCL Cancer Institute, London WC1E 6DD, UK.
Holly Simpson RagdaleSamantha Dickson Brain Cancer Unit, UCL Cancer Institute, London WC1E 6DD, UK.
Andrew BaileyThe Francis Crick Institute, 1 Midland Road, London NW1 1AA, UK.
Mariana Silva Dos SantosThe Francis Crick Institute, 1 Midland Road, London NW1 1AA, UK.
James I MacRaeThe Francis Crick Institute, 1 Midland Road, London NW1 1AA, UK.
Joao MokochinskiMRC London Institute of Medical Sciences, Du Cane Road, London W12 0NN, UK; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
Holger KramerMRC London Institute of Medical Sciences, Du Cane Road, London W12 0NN, UK; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
Claudia Garcia-DiazSamantha Dickson Brain Cancer Unit, UCL Cancer Institute, London WC1E 6DD, UK.
Alex P GouldThe Francis Crick Institute, 1 Midland Road, London NW1 1AA, UK.
Samuel MargueratMRC London Institute of Medical Sciences, Du Cane Road, London W12 0NN, UK; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
Simona ParrinelloSamantha Dickson Brain Cancer Unit, UCL Cancer Institute, London WC1E 6DD, UK. Electronic address: s.parrinello@ucl.ac.uk.
CRUK Lung Cancer Centre of Excellence · GBMRC London Institute of Medical Sciences · GBThe Francis Crick Institute · GBCancer Research UK · GB

Funding

Cancer Research UK 27590Cancer Research UK C55501/A21203Department of Health NIHR-INF-0389Medical Research Council MC-A658-5TY20Medical Research Council MC_UP_A652_1002Wellcome Trust 104566/Z/14/ZWellcome Trust FC001088
6 · The paper itself

Abstract

Glioblastoma is thought to originate from neural stem cells (NSCs) of the subventricular zone that acquire genetic alterations. In the adult brain, NSCs are largely quiescent, suggesting that deregulation of quiescence maintenance may be a prerequisite for tumor initiation. Although inactivation of the tumor suppressor p53 is a frequent event in gliomagenesis, whether or how it affects quiescent NSCs (qNSCs) remains unclear. Here, we show that p53 maintains quiescence by inducing fatty-acid oxidation (FAO) and that acute p53 deletion in qNSCs results in their premature activation to a proliferative state. Mechanistically, this occurs through direct transcriptional induction of PPARGC1a, which in turn activates PPARα to upregulate FAO genes. Dietary supplementation with fish oil containing omega-3 fatty acids, natural PPARα ligands, fully restores quiescence of p53-deficient NSCs and delays tumor initiation in a glioblastoma mouse model. Thus, diet can silence glioblastoma driver mutations, with important implications for cancer prevention.

Indexed as

GlioblastomaNeural Stem CellsAnimalsDietMiceMutationPPAR alphaTumor Suppressor Protein p53PPAR alphaTumor Suppressor Protein p53fatty acid oxidationmetabolismneural stem cellsp53quiescencetumour initiation

Identifiers

PMID37084728
PMCPMC10618406
OpenAlexW4366520899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.